会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Vascular prosthesis and method of making the same
    • 血管假体及其制作方法
    • US4286341A
    • 1981-09-01
    • US041607
    • 1979-05-23
    • Raymond T. GreerBradley H. ValeRandall L. Knoll
    • Raymond T. GreerBradley H. ValeRandall L. Knoll
    • A61F2/00A61F2/06A61L27/14A61L33/06A61F1/24
    • A61L27/14A61F2/06A61L33/064A61F2250/0023
    • A vascular prosthesis and its method of fabrication. The prosthesis takes the form of a flexible and conformable support tube having a luminal surface formed of a smooth, homogenous, and substantially non-thrombogenic hydrogel having relatively small pores or microvoids suitable for tissue ingrowth but resistant to thrombus formation, and having an outer surface formed of essentially the same hydrogel having a heterogenous microstructure which includes relatively large pores or macrovoids especially suitable for cellular ingrowth from perigraft sources and attachment sites. In one embodiment, the tubular substrate is foraminous and the inner and outer hydrogel layers merge through the interstices of the substrate to provide a unified ground substance characterized by strata having selectively different pore characteristics for promoting effective endothelialization and for reducing possibilities of thrombotic occlusion.
    • 血管假体及其制造方法。 假体呈柔性且适形的支撑管的形式,其具有由光滑,均匀且基本上非血栓形成的水凝胶形成的腔表面,其具有适于组织向内生长但抗血栓形成但具有外表面的较小孔或微孔 由具有异质微结构的基本上相同的水凝胶形成,其包含相对较大的孔或大孔,特别适合于来自围网源和附着位点的细胞向内生长。 在一个实施方案中,管状基质是有孔的并且内部和外部水凝胶层合并通过基底的间隙以提供统一的研磨物质,其特征在于具有选择性不同的孔特性的层,用于促进有效的内皮化和减少血栓闭塞的可能性。
    • 7. 发明授权
    • Implantable medical device with compressible fixation member
    • 具有可压缩固定构件的植入式医疗装置
    • US08676319B2
    • 2014-03-18
    • US12915935
    • 2010-10-29
    • Randall L. Knoll
    • Randall L. Knoll
    • A61N1/375
    • A61N1/375
    • An implantable medical device and method of implanting a medical device, the device including a housing surrounding an operative component and a resiliently deformable fixation member. The fixation member includes a ring shaped annulus circumscribing the housing and a plurality of elongated struts having a proximal end affixed to the housing and a distal end affixed to the annulus. The fixation member may be comprised of a hydrogel such that it may be in a smaller, dehydrated form during implantation, and then may absorb fluid to expand to a larger, hydrated form after insertion to engage the surrounding tissue.
    • 一种植入式医疗装置和植入医疗装置的方法,所述装置包括围绕操作部件的壳体和可弹性变形的固定部件。 固定构件包括环绕壳体的环形环形空间和多个细长支柱,其具有固定到壳体的近端和固定到环形空间的远端。 固定构件可以由水凝胶构成,使得其在植入期间可以处于较小的脱水形式,然后可以在插入之后吸收流体以扩大至更大的水合形式以接合周围组织。
    • 10. 发明授权
    • System for enhanced cardiac function with combined PESP/NES
    • 使用PESP / NES组合增强心脏功能的系统
    • US07289850B2
    • 2007-10-30
    • US11116941
    • 2005-04-28
    • John E. BurnesLawrence J. MulliganRandall L. Knoll
    • John E. BurnesLawrence J. MulliganRandall L. Knoll
    • A61N1/36
    • A61N1/3627A61N1/36114A61N1/36564
    • In some embodiments, a method of applying stimulation pulse therapy to excitable tissue may include one or more of the following steps: (a) delivering a PESP stimulation therapy to the excitable tissue for a cardiac cycle, (b) delivering a NES stimulation therapy to the excitable tissue during certain cardiac cycles, (c) determining physiologic demand of the patient based on at least one physiologic measurement, (d) determining physiologic demand being placed on a heart based on at least one physiologic measurement, and ceasing the delivery of the NES and PESP stimulation therapy when physiologic demand returns to a base level, and (e) determining physiologic demand being placed on a heart based on at least one physiologic measurement, and modulating the ratio of the number of cardiac cycles in which the NES stimulation therapy is delivered to the number of cardiac cycles in which the PESP stimulation therapy is delivered based on physiologic demand.
    • 在一些实施方案中,将刺激脉冲治疗应用于可兴奋组织的方法可以包括以下步骤中的一个或多个:(a)将PESP刺激疗法递送至心脏周期的可兴奋组织,(b)将NES刺激疗法递送至 (c)基于至少一个生理测量来确定患者的生理需求,(d)基于至少一个生理测量来确定置于心脏上的生理需求,并且停止递送 NES和PESP刺激治疗,当生理需求恢复到基础水平时,以及(e)基于至少一个生理测量来确定置于心脏上的生理需求,以及调节NES刺激疗法的心脏周期数 基于生理需求被传递到其中递送PESP刺激疗法的心脏周期数。